Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

1.80
Delayed Data
As of Mar 27
 -0.15 / -7.69%
Today’s Change
1.13
Today|||52-Week Range
7.27
-56.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$193.1M

Company Description

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Contact Information

Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands Texas 77381-1160
P:(281) 863-3000
Investor Relations:
(281) 863-3383

Employees

Shareholders

Other institutional82.96%
Individual stakeholders66.16%
Mutual fund holders18.10%

Top Executives

There are no executives to display.